Bioinformatic characterization of the SynCAM family of immunoglobulin-like domain-containing adhesion molecules  by Biederer, Thomas
sevier.com/locate/ygenoGenomics 87 (200Bioinformatic characterization of the SynCAM family of
immunoglobulin-like domain-containing adhesion molecules
Thomas Biederer *
Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520, USA
Received 25 May 2005; accepted 15 August 2005
Available online 28 November 2005Abstract
SynCAM 1 (synaptic cell adhesion molecule 1, alternatively named Tslc1 and nectin-like protein 3) belongs to the immunoglobulin
superfamily and is an adhesion molecule that operates in a variety of important contexts. Exemplary are its roles in adhesion at synapses in the
central nervous system and as tumor suppressor. Here, I describe a family of genes homologous to SynCAM 1 comprising four genes found solely
in vertebrates. All SynCAM genes encode proteins with three immunoglobulin-like domains of the V-set, C1-set, and I-set subclasses. Comparison
of genomic with cDNA sequences provides their exon–intron structure. Alternative splicing generates isoforms of SynCAM proteins, and diverse
SynCAM 1 and 2 isoforms are created in an extracellular region rich in predicted O-glycosylation sites. Protein interaction motifs in the cytosolic
sequence are highly conserved among all four SynCAM proteins, indicating their critical functional role. These findings aim to facilitate the
understanding of SynCAM genes and provide the framework to examine the physiological functions of this family of vertebrate-specific adhesion
molecules.
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large group of proteins with diverse roles in extracellular
recognition [1]. SynCAM 1 (synaptic cell adhesion molecule 1;
human gene symbol IGSF4) belongs to this superfamily and is
a membrane protein that functions as intercellular adhesion
molecule in several tissues, including the brain. SynCAM 1
contains three extracellular Ig-like domains, a single trans-
membrane sequence, and a short cytosolic tail sporting two
identified protein–protein interaction motifs.
Different SynCAM family members have been identified by
a number of independent approaches. SynCAM 1 serves as
synaptic adhesion molecule in the central nervous system and
is expressed throughout the brain [2]. It is localized to synaptic
plasma membranes, where it engages in an interaction that
bridges the synaptic cleft [2]. Notably, SynCAM 1 is sufficient
to induce neurons to form functional presynaptic specializa-
tions and promotes synaptic transmission [2,3]. All activities of0888-7543/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: thomas.biederer@yale.edu.SynCAM 1 identified in neurons depend on its extracellular,
Ig-like domain-mediated interactions [2,3]. SynCAM 1 was
also reported to mediate the attachment of mast cells to neurites
[4]. Independently, SynCAM 1 was mapped and cloned as a
potential tumor suppressor gene [5,6]. This role was confirmed
by analysis of SynCAM 1-expressing tumor cells in immuno-
compromised mice, leading to the alternative naming of
SynCAM 1 as tumor suppressor in lung cancer 1 (Tslc1) [7].
In addition, SynCAM 1 was cloned from PC12 cells as a
retinoic-acid-inducible gene, implicating it in the differentia-
tion of these cells to a neuron-like morphology [8], and as an
Ig-domain-containing protein expressed in testis during sper-
matogenesis, leading to its naming as SgIGSF (spermatogenic
immunoglobulin superfamily member) [9]. SynCAM 1 tran-
scripts are abundant in brain, present in testis, and also more
weakly detected in other tissues ([9,10] and T. Biederer et al.,
unpublished observations). A different family member, Syn-
CAM 3, is expressed in epithelia and was named nectin-like
protein 1 (necl-1) due to its overall domain organization, which
is similar to that of nectin [11]. Functional roles for SynCAMs
2 and 4 remain to be identified.6) 139 – 150
www.el
Table 1
Genes and nomenclatures
Human gene
symbol
IGSF4 IGSF4D IGSF4B IGSF4C
Mouse gene
symbol
Igsf4a Igsf4d Igsf4b Igsf4c
Protein name SynCAM 1 [2] SynCAM 2 [2] SynCAM 3 [2] SynCAM 4 [2
Alternate
protein
names
Necl-2 [14] Necl-3 [15] Necl-1 [11]
Tslc1 [7] Tsll1 [45] Tsll2 [45]
SgIGSF [9]
RA175 [8]
Human and mouse genes beginning with IGSF4 and Igsf4, respectively, encode
SynCAM proteins. Different names used for individual SynCAM proteins
are listed. Ensembl gene IDs for IGSF4, IGSF4B, IGSF4C, and IGSF4D
are ENSG00000182985, ENSG00000175161, ENSG00000162706, and
ENSG00000105767, respectively. The Ensembl gene IDs for Igsf4a, Igsf4b
Igsf4c, and Igsf4d are ENSMUSG00000032076, ENSMUSG00000064115
ENSMUSG00000005338, and ENSMUSG00000054793.
T. Biederer / Genomics 87 (2006) 139–150140A protein family relevant to the SynCAM adhesion
molecules comprises the above-mentioned nectins, a group
of four immunoglobulin superfamily members (reviewed in
[12,13]). Nectins are expressed in a variety of tissues and are
involved in intercellular adhesion in epithelial and neural
tissues, most prominently at adherens junctions. SynCAM and
nectin proteins exhibit an overall similar domain organization
with three extracellular Ig-like domains, a single transmem-
brane region, and a carboxy-terminal intracellular tail. How-
ever, SynCAM and nectin proteins are not homologous. They
share only a low sequence identity, and their Ig-like domains
are not related (data not shown). Furthermore, the intracellular
tails of SynCAM proteins, characteristic of this protein family
(see below), are not similar to those of nectins. Interestingly,
the extracellular domains of SynCAM 1 and nectin 3 interact
with each other, as well as the extracellular domains of
SynCAM 3 and nectins 1 and 3 [11,14]. Functional roles of
these interactions remain to be characterized.
In light of the important functions SynCAM proteins exert
in different physiological contexts ranging from the differen-
tiation of synapses in the brain to tumor suppression, it is
necessary to characterize this gene family. I here show that the
SynCAM family consists of four conserved members. All
SynCAM proteins display the same domain organization as
SynCAM 1. Genes encoding SynCAM family members are
found throughout vertebrate genomes from puffer fish to
humans, but are absent in invertebrates. While SynCAM
protein sequences are relatively conserved, the genes encoding
them display remarkable size differences up to 60-fold in
humans and mice. Furthermore, three of the four genes
encoding SynCAM family members undergo alternative
splicing in humans and mice, but the number and location of
alternatively spliced exons vary between them. Particularly, the
analysis of splice patterns draws attention to the juxtamem-
branous region of the extracellular domain of SynCAM 1 and 2
and potential functional roles of this sequence and its splicing.
In addition, this study shows that the carboxy-terminal
intracellular tails of SynCAMs are the most conserved
sequences, indicating the critical role of cytosolic protein–
protein interaction motifs for the functions of SynCAMs. This
analysis aims to further our understanding of the roles of
SynCAM proteins in the differentiation of tissues such as the
developing brain and as tumor suppressors.
Results
The SynCAM family comprises four genes, encoding
proteins with three Ig-like domains, a single transmembrane
region, and a short cytosolic tail with a protein 4.1 interaction
sequence and a PDZ type II motif (see below for an analysis of
these genes and their sequence features). Different names are
used for individual SynCAM family members (Table 1 and
references therein). To clarify their nomenclature, I propose to
name these proteins SynCAM 1, 2, 3, and 4 for the following
reasons. First, the high degree of conservation on the amino
acid level warrants the classification of SynCAM proteins as a
family (see below). Second, this classification as gene family is]
,
,independently supported by the highly similar exon usage of
the four SynCAM genes. Third, this nomenclature was used in
the first published reference to this protein family [2]. Fourth,
the nomenclature as SynCAMs proposed here is the only
homology-based classification that includes all family mem-
bers. Fifth, while it has been proposed to refer to these proteins
as nectin-like molecules or nectin-like proteins (necl) based on
similarities in their domain organization [15], this does not
appear fitting on homology grounds, as that classification
includes two nonhomologous proteins (the poliovirus receptors
necl-5 and necl-6 [15]). Last, the gene symbol IGSF4
(immunoglobulin superfamily member 4) appears neither
useful nor fitting for naming the protein. It is not indicative
of a function, and IGSF 1, 2, and 3 are not homologous to the
SynCAM family. I therefore propose that these four genes are
referred to as the SynCAM family, based on their homology to
SynCAM 1.
The SynCAM family of membrane proteins comprises four
members
SynCAM sequences and splice products were identified in
database searches as described under Methods and are listed in
Supplementary Table S1. Four human SynCAM family
members can be identified that share a high degree of amino
acid identity, ranging for the full-length proteins from 50%
(SynCAM 2 vs 3) to 36% (SynCAM 1 vs 3 or 4). The
significant conservation of their three extracellular Ig-like
domains is apparent in the alignment of their sequences (Fig. 1;
see below for an analysis). In addition, this alignment
highlights the striking similarity of the intracellular carboxy-
terminal sequences of SynCAM proteins (Fig. 1) and their
conserved intracellular interaction motifs with protein 4.1 and
PDZ type II domains (see below).
A phylogenetic comparison of human and mouse SynCAM
full-length sequences classifies SynCAMs 2 and 3 as more
closely related to each other than to SynCAM 1 (Fig. 2).
SynCAM 4 is a more distant family member. This interpreta-
tion is confirmed by a detailed analysis of their individual
Ig-like domains (see below). All human SynCAM family
Fig. 1. Human SynCAM genes are conserved and share the same modular organization. The sequence alignment of human SynCAMs 1, 2, 3, and 4 shows their
identical overall organization and strong sequence conservation. Extracellular Ig-like domains of SynCAM proteins are highly related, and their intracellular sequences
are very similar. Filled boxes mark amino acids identical in all four human SynCAM proteins, bold letters indicate conserved residues, and open boxes show sequences
of high similarity. The predicted signal peptide is shown in italic. Asterisks mark the predicted transmembrane domain. Ig-like domains are shown on a blue
background, and N-glycosylation consensus sites are shown in open red boxes. Note that while all N-glycosylation consensus sites are indicated, the modification of
extreme amino-terminal sites such as those indicated in SynCAMs 2, 3, and 4 is generally unfavorable. Conserved cytosolic protein 4.1 and PDZ type II interaction
motifs are indicated (see text for details). Human sequences used for alignment are SynCAM 1 splice product 4, SynCAM 2 splice product 2, SynCAM 3 splice
product 2, and SynCAM 4 splice product 1. For a list of Ensembl transcript IDs and EST clone numbers representing the human splice products shown, please see
Supplementary Table S1.
T. Biederer / Genomics 87 (2006) 139–150 141members have mouse orthologs that are highly conserved,
exhibiting pair-wise amino acid identities of 95–99% (Sup-
plementary Fig. S1).
The features of SynCAM Ig-like domains allow their
classification
The most prominent features of SynCAM sequences are
their three extracellular Ig-like domains in combination with an
intracellular PDZ consensus motif. All SynCAM proteins
presumably mediate cell adhesion through these Ig-like
domains similar to SynCAM 1 [2], and their properties are
therefore critical for understanding SynCAM function.
Ig domains comprise two h sheets, each consisting of
several short antiparallel h strands, which fold into a sandwich-
like structure with a hydrophobic core. Typically, a disulfidebridge connects the two h sheets. Ig domains differ in the
number of strands in each of the h sheets, resulting in different
topologies [1,16,17]. Sequence analyses delineated the immu-
noglobulin superfamily into major sets corresponding to
different folds, and these classifications are guided and
corroborated by structural studies.
In the absence of protein structural information for
SynCAM proteins, a classification of their Ig-like domains
was performed using sequence information. This analysis was
based on alignments of mouse and human SynCAM Ig-like
domains with domains of known structure as described under
Methods. The obtained results were further substantiated by an
analysis based on sequence features typical of the different Ig
domain subclasses [16–19].
Based on this sequence analysis, the first Ig-like domain of
all four SynCAM proteins belongs to the V-set subclass, which
Fig. 2. Phylogenetic analysis of human and mouse SynCAM. The phylogenetic
analysis of SynCAM family members shows their conservation in human and
mouse. SynCAMs 2 and 3 are more related to each other than to other
SynCAMs. Human sequences used for this analysis and identity calculations
(see text) are the transcripts shown in Fig. 1. Mouse sequences are the
corresponding splice products of the orthologs. Ensembl transcript IDs and EST
clone numbers representing the individual splice products are listed in
Supplementary Table S1.
T. Biederer / Genomics 87 (2006) 139–150142is predicted to have a nine-h-stranded topology, similar to the
variable (V) chain of Ig domains. The second Ig-like domain of
SynCAM proteins is more divergent and shares fewer features
with known domains. It belongs to the C1-set subclass of
Ig-like domains (Ig constant chain-like subclass C1) and is
predicted to have a topology comprising seven h-strands.
Several criteria allow this classification of the second Ig-like
domain. It shares significant sequence similarity to known
domains of the C1 subclass in sequence alignments (data not
shown). Further, the number of amino acids between the
cysteines forming the disulfide bond (53–56 amino acids
depending on the SynCAM gene) is close to the typical range
of 54–64 amino acids for the C1 subclass. In addition, the
absence of an aromatic residue at position F1 (the first residue
of predicted h-strand F) and the presence of a conserved
tryptophan residue at position C5 (the fifth residue of predicted
h-strand C) is typical of C1-set Ig-like domains. The third Ig-
like domain of SynCAMs belongs to the I-set subclass with an
eight-h-stranded topology (referred to as h-type fold in [16]),
based on its high sequence similarity to Ig-like domains of
this subclass with known structure.
Almost all SynCAM Ig-like domains feature an intra-
domain disulfide bridge. The only identified exception is
chicken SynCAM 1 (Fig. 7), which lacks a disulfide bridge
in the second Ig-like domain. This can occur, albeit rarely,
in Ig-like domains without affecting the tertiary structure
[1].Fig. 3. Exon– intron structure and alternative splice products of human IGSF4 and mo
Data are based on the analysis of human and mouse genome sequences in the NCBI d
subject to alternative splicing. A cryptic mouse exon homologous to human exon 9
positions of the exons and introns in the human and mouse genes encoding SynCAM1
splicing. Positions of the genes are shown on the top of each diagram as contained in
variants of human SynCAM 1 as identified in EST databank searches. The number iIt is notable that the first and third Ig-like domains of all
SynCAM proteins feature potential N-glycosylation sites that
correspond to the required consensus sequence Asn-Xaa-Ser/
Thr (where Xaa is not Pro). A sequence analysis predicts that
these sites are likely to have glycosylated asparagines (see
Methods). The comparison of the individual human and mouse
orthologs demonstrates that all their predicted N-glycosylation
sites are identical. With respect to the SynCAM family as a
whole, the potential N-glycosylation sites in the third Ig-like
domain tend to be most conserved. In agreement with this
analysis, SynCAM proteins are N-glycosylated ([2] and data
not shown).
The distinct features of the three Ig-like domains of
SynCAM proteins allow for a more detailed sequence
comparison. The corresponding Ig-like domains of human
and mouse SynCAMs are highly related, as evident from their
alignment (Supplementary Fig. S2). Relationships among
SynCAM family members also are apparent in a phylogenetic
tree analysis of their Ig-like domains (Supplementary Fig.
S3). Here, the separate alignment of the three Ig-like domains
shows the closest sequence similarity for domains of
SynCAM 2 and 3. This corroborates the identical result
obtained from the analysis of full-length SynCAM sequences
(Fig. 2).
The cytosolic tail and protein–protein interaction motifs of
SynCAMs are remarkably conserved
The carboxy-terminal intracellular sequences of SynCAM
proteins constitute a remarkably conserved region of this
family, both between family members (Fig. 1) and across
species (Fig. 7). Functional studies of SynCAM 1 have
demonstrated that this intracellular sequence is necessary for
the activity of SynCAM 1 to promote synaptic transmission
in neuronal cultures [3], highlighting the important role of the
cytosolic tail for SynCAM function. While secondary
structure predictions for the cytosolic tail are not informative
(data not shown), a sequence analysis indicates two separate
protein–protein interaction motifs in this comparatively short
sequence.
First, the intracellular sequences of SynCAM proteins share
a juxtamembranous motif predicted to interact with members of
the protein 4.1 family (Fig. 1). Protein 4.1 family members are
expressed in a wide variety of tissues, where they promote and
stabilize the assembly of actin/spectrin cytoskeleton [20]. They
recognize a sequence motif initially identified in the erythro-
cyte membrane protein glycophorin C [21–23], which is also
present in the neurexin family of synaptic adhesion molecules
[24]. This protein 4.1 interaction sequence is conserved among
SynCAM family members (Fig. 1).use Igsf4 genes encoding SynCAM 1. (A) Locations of exon– intron boundaries.
atabases. Chromosomal locations are indicated. Exons labeled with asterisks are
is located at bp 47,941,151–47,941,204 (see text). (B) Diagrams depicting the
. Exons are identified by numbers, and asterisks mark exons subject to alternative
the NCBI databases. SP, splice product. (C) Protein sequences encoded by splice
ndicates the amino acid encoded by the codon at the respective exon junction.
T. Biederer / Genomics 87 (2006) 139–150 143Second, the cytosolic tail of all SynCAM proteins ends in
a carboxy-terminal sequence predicted to interact with PDZ
domains of the type II class (Fig. 1) [25]. PDZ domainscharacterize a common group of adaptor molecules, which
often bind to membrane proteins and serve important functions
in their scaffolding and targeting [26]. The predicted interaction
T. Biederer / Genomics 87 (2006) 139–150144of SynCAM 1 with several PDZ-domain-containing proteins
has been confirmed [2].
Human and mouse genes encoding SynCAM proteins display
distinct exon–intron structures and alternative splicing
These protein sequence analyses demonstrate striking
similarities of SynCAM proteins. Their gene structures,
however, reveal interesting variations of both exon–intron
structures and alternative splice patterns.
Human and mouse genes that encode SynCAM 1 comprise
12 and 11 exons, respectively. Alternative splicing generates five
splice products (Fig. 3; chromosomal locations of genes are
stated in Figs. 3–6). The difference in exon number between
human and mouse SynCAM 1 orthologs is due to human exon
10, which is not found in transcripts of mouse SynCAM 1.
However, a cryptic exon-like sequence exists downstream of
exon 9 of mouse Igsf4a. It contains appropriate flanking splice
acceptor and donor sites and is homologous in sequence to exon
10 of the IGSF4 gene encoding human SynCAM 1 (see Fig. 3A
legend), accentuating the homology of SynCAM family
members at the genomic level. This cryptic sequence is probably
not expressed inmouse, as database searches did not identify any
transcripts containing it (data not shown). It is notable that the
first intron of human SynCAM 1 is 264 kb in size, very large
relative to the gene’s size of 328 kb.
SynCAM 1 is the family member with the highest degree of
alternative splicing (Fig. 3B). Database searches identify five
alternatively spliced transcripts of human and mouse SynCAM
genes encoding SynCAM 1 proteins. All alternative splicing
occurs directly upstream of the exon encoding the transmem-
brane region, i.e., the juxtamembranous extracellular region of
SynCAM 1. The first four alternative splice products encoding
SynCAM 1 differ in their content of potential O-glycosylation
sites in this region of the molecule (Fig. 3C). These splice
products (SP) encode SynCAM 1 proteins with either a highly
threonine-rich sequence consisting almost entirely of potential
O-glycosylation sites (SP 4), or the same sequence further
extended by potential O-glycosylation sites (SP 1), or a partial
sequence of the latter extended by a stretch of a few potential
O-glycosylation sites (SP 2). A splice product lacking O-
glycosylation sites also exists (SP 3). Interestingly, a fifth splice
product (SP 5) encodes a secreted form of the SynCAM 1
extracellular domain. All splice forms of SynCAM 1 are found
among both human and mouse transcripts, corroborating this
analysis. It is also notable that the length of each exon and
intron is highly comparable for the human and mouse genes.
SynCAM 2 is encoded by 10 exons in humans and by 11
exons in mice (Fig. 4A). Alternative exon usage and splicing
generate three human and two mouse SynCAM 2 transcripts
(Fig. 4B). Two alternatively used first exons exist in the human
gene encoding SynCAM 2, which have different signal
peptides resulting in the splice products SP1 and SP2
(containing exon 1a, but not exon 1b) and SP3 (containing
exon 1b, but not exon 1a). This alternative use of a first exon in
human SynCAM 2 does not occur in mice and represents the
only divergence of exon–intron structures between human andmouse orthologs. However, the sequence of mouse exon 2 is
89% identical to the sequence encoded by the 3V end of human
exon 1b. This allows an insight into the evolutionary
mechanism behind this divergence and underscores the
evolutionary conservation among SynCAM genes.
Alternative splicing of transcripts encoding SynCAM 2
occurs upstream of the exon encoding the transmembrane
region similar to SynCAM 1. Yet, these splice variations are
simple. Only one exon encodes a threonine-rich sequence
corresponding to potential O-glycosylation sites, resulting in
two different splice products containing or lacking this sequence
(human SP1/SP3 and SP2, respectively) (Fig. 4C). Notably, the
gene encoding SynCAM 2 is the largest of the family. While the
human gene encoding SynCAM 1 is 328 kb in length, and
human SynCAMs 3 and 4 are very compact with 29 and 16 kb,
respectively (see below), the human gene encoding SynCAM 2
has the remarkable size of 1.11 Mb. As for SynCAM 1, the first
intron accounts for the bulk of the gene size, with 843 kb for
splice products 1 and 2 of human SynCAM 2.
The gene encoding SynCAM 3 consists of 10 exons in both
human and mouse genomes (Fig. 5A). Alternative splicing
occurs for exon 2, leading to the presence or lack of a sequence
in the transcript immediately following the signal peptide
(mouse and human SP1 or SP2, respectively) (Fig. 5B). This
sequence has no notable features, and its role is not evident. No
other splice variants were observed in extensive searches of
EST databases, and the protein encoded by this gene lacks the
stretch of potential O-glycosylation sites present in SynCAM 1
and 2 isoforms.
The gene encoding SynCAM 4 consists of nine exons in both
human and mouse genomes (Figs. 6A and 6B). It is very
compact, making the gene encoding human SynCAM 4 with 16
kb the smallest gene of the family. No alternative splicing was
identified after comparison of genomic and cDNA sequences.
As for SynCAM 3, the SynCAM 4 protein does not feature the
stretch of predicted extracellular O-glycosylation sites found
carboxy-terminal to the Ig-like domains in SynCAMs 1 and 2.
All exon–intron boundaries in genes encoding SynCAM
family members conform to standard splice acceptor (AG) and
splice donor (GT) sites (Figs. 3A, 4A, 5A, and 6A). Most exons
are separated from each other by introns located after the first
nucleotide of the codon (phase 1). The phase match may allow
for evolutionary joining of modules without disrupting coding
sequences and agrees with the modular structure of these genes.
This phasing of exon–intron boundaries applies to all introns
except for one intradomain intron separating the two exons
encoding the third Ig-like domain. This intron is located after the
codon’s second nucleotide (phase 2) in all genes encoding
SynCAM proteins.
SynCAMs are vertebrate-specific genes of highly conserved
sequence
SynCAMs are found throughout vertebrate genomes (Fig. 7).
The alignment of human SynCAM1with orthologs frommultiple
other species, including puffer fish and chicken, emphasizes the
strong evolutionary conservation of both the three extracellular
Fig. 4. Exon– intron structure and alternative splice products of human IGSF4D and mouse Igsf4d genes encoding SynCAM 2. (A) Locations of exon– intron
boundaries. Data are based on the analysis of human and mouse genome sequences in the NCBI databases. Chromosomal locations are indicated. Exons labeled with
asterisks are alternatively spliced. Exons labeled ‘‘a’’ and ‘‘b’’ contain alternative splice donor sites. (B) Diagrams depicting the positions of the exons and introns in
the human and mouse genes encoding SynCAM 2 as described in the legend to Fig. 3. (C) Protein sequences encoded by splice variants of human SynCAM 2 as
described in the legend to Fig. 3.
T. Biederer / Genomics 87 (2006) 139–150 145Ig-like domains and the carboxy-terminal intracellular sequence
in vertebrates. A phylogenetic analysis shows that the SynCAM1
protein from puffer fish is most distant from human, with which it
shares 56% amino acid identity, followed by chicken and dog
SynCAM 1. Mouse and human SynCAM 1 are most closely
related and share 98% amino acid identity.
The immunoglobulin superfamily is well represented in
invertebrate genomes, as studied in detail for the nematodeCaenorhabditis elegans [27,28] and the arthropod Drosophila
melanogaster [29,30]. However, searches with SynCAM
sequences did not reveal significantly similar genes in inverte-
brate genomes. The only sequences identified in these homology
searches encoded isolated invertebrate Ig-like domains, sharing
a low sequence identity too small to be significant, considering
the notable overall sequence similarity of these domains (data
not shown). Further, none of those invertebrate immunoglobulin
Fig. 5. Exon– intron structure and alternative splice products of human IGSF4B and mouse Igsf4b genes encoding SynCAM 3. (A) Locations of exon– intron
boundaries. Chromosomal locations are indicated. Data are based on the analysis of human and mouse genome sequences in the NCBI databases. Exons labeled with
asterisks are subject to alternative splicing. (B) Diagrams depicting the positions of the exons and introns in the human and mouse genes encoding SynCAM 3 as
described in the legend to Fig. 3.
T. Biederer / Genomics 87 (2006) 139–150146superfamily members with weakly similar Ig-like domains
exhibited the characteristic extracellular organization of Syn-
CAMs with three sequentially arranged Ig-like domains (data
not shown). The analyzed invertebrate genomes contain
immunoglobulin superfamily members with an extracellular
domain organization similar to SynCAM proteins. Nevertheless,
none of them showed significant sequence similarities either in
the Ig-like domains or in the SynCAM trademark features of the
cytosolic protein–protein interaction motifs. In summary, no
evidence exists for SynCAMhomologs in invertebrate genomes.
Discussion
The diverse functions of immunoglobulin superfamily
members elicit a strong interest in this class of proteins,notably in the central nervous system [31]. The recent
characterization of the synaptic adhesion molecule SynCAM
1 further aids this development and has led to the identification
of the SynCAM family as a new group of immunoglobulin
superfamily members. SynCAM homologs are present
throughout vertebrate genomes, and the analysis of transcripts
and genomic databases described here revealed that the
SynCAM family comprises four genes. Notably, no SynCAM
homologs could be identified in invertebrates.
All SynCAM family members share the same modular
organization across species boundaries (Figs. 1 and 7). Directly
after the signal peptide, the extracellular domain is defined by
three Ig-like domains connected by short linker regions. Based
on sequence analysis, the SynCAM Ig-like domains belong to
the V-, C1-, and I-set subclasses, and future structural studies
Fig. 6. Exon– intron structure and alternative splice products of human IGSF4C and mouse Igsf4c genes encoding SynCAM 4. (A) Locations of exon– intron
boundaries. Data are based on the analysis of human and mouse genome sequences in the NCBI databases. Exon 1 of mouse SynCAM 4 could not be assigned in the
available databases due to insufficient quality of sequences in this region. A splice variant lacking exon 5 was identified in EST databank searches, but was present
only among mouse transcripts and was represented by few clones. This variant was therefore not included in our analysis. (B) Diagrams depicting the positions of the
exons and introns in the human and mouse genes encoding SynCAM 4 as described in the legend to Fig. 3.
T. Biederer / Genomics 87 (2006) 139–150 147will have to test this prediction. These Ig-like domains can be
followed by an O-glycosylation stalk in SynCAM 1 and, to
lesser extent, in SynCAM 2. The single transmembrane region
continues into a highly conserved cytosolic tail.
Sequence conservation of SynCAM proteins follows func-
tion. Their extracellular domains engage in homo- and
heterophilic interactions ([2,14,32] and Fogel, Akins, and
Biederer, unpublished observations) that are presumably in
all cases mediated by the Ig-like domains as shown for
SynCAM 1 [2]. Furthermore, the highly conserved cytosolic
tails bind several adaptor molecules ([2,11] and Biederer et al.,
unpublished observations). Yet, two significant differences
exist between SynCAM proteins. On the one hand, SynCAM 1
and 2 proteins are distinguished as a result of alternative
splicing by the presence or lack of extracellular regions
containing potential O-glycosylation sites. On the other, only
a few predicted N-glycosylation sites are conserved among all
SynCAM homologs.SynCAM 1 is particularly open to functional variability that
could arise from alternative splicing. Three SynCAM 1 splice
products contain a stalk with stretches of predicted O-
glycosylation sites. Multiple proline residues are close to these
threonines, consistent with O-glycosylation occurring at the
majority of those sites [33]. This stretch of O-glycosylation
sites is a feature shared by SynCAM 1 with other cell surface
proteins, and the extensive modification of this stretch with
charged O-linked carbohydrates is likely to shape this region
into an extended conformation. The O-glycosylation stalk
could thereby space the Ig-like domains away from the plasma
membrane and affect their interactions with extracellular
binding partners. Notably, one splice variant of SynCAM 1
identified in this analysis results in the expression of its
secreted extracellular domain. This prediction was recently
confirmed [34]. This SynCAM 1-specific isoform may serve
non-cell contact-based signaling functions during tissue
development.
Fig. 7. SynCAM 1 alignment from different vertebrate species. The sequence alignment of human, mouse, dog, chicken, and puffer fish SynCAM 1 sequences
emphasizes its strong conservation among vertebrates. Sequence annotations are explained in the legend to Fig. 1. The GenBank accession numbers for full-length
SynCAM 1 sequences are AF539424 (mouse, Mus musculus) and XM_536568 (dog, Canis familiaris). Additional sequences were assembled after searches of
NBCI databases for chicken EST clones (Gallus gallus, BI392621, BU419715, BU271319) and for puffer fish after searches of NBCI EST and IMCB Fugu Genome
Project (http://www.fugu-sg.org/) databases (Fugu rubripes, FuguGenscan_13966, SINFRUP00000053915).
T. Biederer / Genomics 87 (2006) 139–150148Further insight into the molecular properties of SynCAMs
can be gained from their most conserved region, the cytosolic
sequence. This tail sequence is necessary for SynCAM 1 to
promote synaptic transmission in neurons [3] and it can be
presumed that it is of critical importance for the function of allfamily members. First, it contains a protein 4.1 interaction
motif (Fig. 1). As members of the protein 4.1 family affect the
assembly of the actin/spectrin cytoskeleton [20], this interac-
tion could provide a physical link for SynCAM proteins to
cytoskeletal filaments. Such a connection to the cytoskeleton is
T. Biederer / Genomics 87 (2006) 139–150 149a common feature of adhesion molecules, as this can support
their proper arrangement within the plasma membrane. The
predicted protein 4.1 interaction therefore agrees with Syn-
CAM function in intercellular interactions.
In addition, the conserved PDZ domain interactions of
SynCAM proteins are likely to be functionally important, as
demonstrated by studies of SynCAM 1. Here, only the intact
cytosolic SynCAM 1 tail affected the number and physiolog-
ical properties of presynaptic terminals in cultured neurons,
while mutations in the PDZ interaction consensus motif
abolished this effect [2]. Taken together, both the intracellular
interaction motifs of SynCAM proteins with protein 4.1 family
members and with PDZ-domain-containing adaptor molecules
described here are likely to be generally relevant for their
functions as adhesion molecules.
Moving from the SynCAM protein sequences to their genes,
this analysis demonstrates that they share multiple properties in
their exon–intron structure. All exons contain protein-coding
sequences. The splice acceptor/donor site phases of the exons are
conserved among all four genes. In addition, the first exon of
each gene encodes a signal peptide as defined by a predicted
signal peptidase cleavage site. This also applies to the first
alternatively used exon of the gene encoding human SynCAM2,
which generates two alternate transcripts encoding different
signal peptides. Each Ig-like domain is encoded by two exons,
typical for these domains [35–37]. The transmembrane region
and the cytosolic sequence of SynCAM proteins are encoded by
the last two exons, respectively.
Further similarities exist for each of the four orthologs in
human and mouse. The lengths of introns are highly
comparable for the human and mouse SynCAM orthologs
and often identical for their exons. Notably, the different
splice patterns of SynCAM transcripts are identical for the
human and mouse orthologs. The features of the gene
encoding SynCAM 2 attract further attention. While the
SynCAM 2 and 3 proteins are the closest family members on
the amino acid sequence level, their gene size structures and
alternative splicing are quite different. Also, the relatively
large size of the SynCAM 2 gene predicts a transcription time
of 8 h based on results obtained for the dystrophin gene,
which is cotranscriptionally spliced [38].
Overall, the homologous exon–intron structure of the four
genes encoding SynCAM proteins, together with the con-
served alternative splicing among orthologs and their high
protein sequence similarity, highlights the strong evolutionary
conservation of this gene family in vertebrates. Future studies
will have to address whether SynCAM proteins also share the
same functions across species.
Methods
SynCAM genes and isoforms were identified in National Center for
Biotechnology Information (NCBI) databases using homology BLAST searches
with standard settings (http://www.ncbi.nlm.nih.gov/BLAST/). In addition,
sequences were retrieved from the Ensembl project of the Sanger Institute
(http://www.ensembl.org/) and the TIGR gene indices (http://www.tigr.org/).
Multiple cDNA sequences for the isoforms were identified in searches of EST
databases. cDNA sequences were aligned within the genomic sequence using theEnsembl project database and the GeneWise software (version 2.1, available at
the EMBLEuropean Bioinformatics institute, http://www.ebi.ac.uk/Wise2/) [39]
and analyzed for splice acceptor/donor sites. Representative sequence files used
in this analysis are listed in Supplementary Table S1.
Multiple sequence alignments were performed using the T-Coffee method,
based on a Lalign and ClustalW pair-wise prealignment approach with
progressive optimization of the alignments [40]. T-Coffee alignments were
performed using standard settings of the program, accessible at http://
www.ch.embnet.org/software/TCoffee.html. Amino acid identities of sequences
were determined after their pair-wise alignment using ClustalW with the
Gonnet protein weight matrix and settings of a gap open penalty of 10, a gap
extension penalty of 0.1, and no gap separation penalty (accessible at http://
www.npsa-pbil.ibcp.fr/). Phylogenetic analyses and their plot as cladogram-like
rooted trees were conducted with the Phylogeny Inference Package (version
3.6) based on multiple bootstrapped data sets using standard settings, accessible
at http://www.bioweb.pasteur.fr/ [41].
Prediction of transmembrane helices was performed using the TMHMM
Server (version 2.0), which models transmembrane helix core, caps, and loops
based on a hidden Markov model using standard settings (accessible at http://
www.cbs.dtu.dk/) [42]. Signal peptides were predicted using the PSORT II
program, based on an expert system trained on a SWISS-PROT database
(accessible at http://www.psort.nibb.ac.jp/) [43].
The analysis and classification of the SynCAM Ig-like domains were
performed based on sequence alignments with domains of known structure
using the Protein families database of alignments (Pfam), accessible at http://
www.sanger.ac.uk/Software/Pfam/search.shtml). Searches were performed us-
ing both global and fragment-type Pfam searches using standard settings. This
classification was refined based on the sequence elements described and
referenced in the text.
Probable N-glycosylation sites were predicted using the NetNglyc server
expert system (version 1.0; accessible at http://www.cbs.dtu.dk/services/
NetNGlyc/). Likely mucin-type GalNAc O-glycosylation sites were predicted
with the NetOglyc server (version 3.2; accessible at http://www.cbs.dtu.dk/
services/NetOGlyc/ [44].
Acknowledgments
I thank the members of my laboratory for helpful discus-
sions and Sreeganga Chandra and Tony Koleske for valuable
comments on the manuscript. This study was supported by The
Brain Tumor Society, a March of Dimes Foundation Basil
O’Connor Award (5-FY05-138), and National Institute on
Drug Abuse Grant R01-DA018928.
Appendix A. Supplementary data
Supplementary data associated with this article can be found
in the online version at doi:10.1016/j.ygeno.2005.08.017.
References
[1] A.F. Williams, A.N. Barclay, The immunoglobulin superfamily domains
for cell surface recognition, Annu. Rev. Immunol. 6 (1988) 381–405.
[2] T. Biederer, Y. Sara, M. Mozhayeva, D. Atasoy, X. Liu, E.T. Kavalali,
T.C. Su¨dhof, SynCAM, a synaptic adhesion molecule that drives synapse
assembly, Science 297 (2002) 1525–1531.
[3] Y. Sara, T. Biederer, D. Atasoy, A. Chubykin, M.G. Mozhayeva, T.C.
Su¨dhof, E.T. Kavalali, Selective capability of SynCAM and neuroligin for
functional synapse assembly, J. Neurosci. 25 (2005) 260–270.
[4] T. Furuno, A. Ito, Y.-i. Koma, K. Watabe, H. Yokozaki, J. Bienenstock, M.
Nakanishi, Y. Kitamura, The spermatogenic Ig superfamily/synaptic cell
adhesion molecule mast-cell adhesion molecule promotes interaction with
nerves, J. Immunol. 174 (2005) 6934–6942.
[5] H. Gomyo, Y. Arai, A. Tanigami, Y. Murakami, M. Hattori, F. Hosoda, K.
Arai, Y. Aikawa, H. Tsuda, S. Hirohashi, S. Asakawa, N. Shimizu, E.
T. Biederer / Genomics 87 (2006) 139–150150Soeda, Y. Sakaki, M. Ohki, A 2-Mb sequence-ready contig map and a
novel immunoglobulin superfamily gene IGSF4 in the LOH region of
chromosome 11q23.2, Genomics 62 (1999) 139–146.
[6] M.T. Pletcher, T. Nobukuni, H. Fukuhara, M. Kuramochi, T. Maruyama,
T. Sekiya, T. Sussan, M. Isomura, Y. Murakami, R.H. Reeves,
Identification of tumor suppressor candidate genes by physical and
sequence mapping of the TSLC1 region of human chromosome 11q23,
Gene 273 (2001) 181–189.
[7] M. Kuramochi, H. Fukuhara, T. Nobukuni, T. Kanbe, T. Maruyama,
H.P. Ghosh, M. Pletcher, M. Isomura, M. Onizuka, T. Kitamura, T.
Sekiya, R.H. Reeves, Y. Murakami, TSLC1 is a tumor-suppressor
gene in human non-small-cell lung cancer, Nat. Genet. 27 (2001)
427–430.
[8] K. Urase, A. Soyama, E. Fujita, T. Momoi, Expression of RAI75 mRNA,
a new member of the immunoglobulin superfamily, in developing mouse
brain, NeuroReport 12 (2001) 3217–3221.
[9] T.Wakayama, K. Ohashi, K.Mizuno, S. Iseki, Cloning and characterization
of a novel mouse immunoglobulin superfamily gene expressed in early
spermatogenic cells, Mol. Reprod. Dev. 60 (2001) 158–164.
[10] T. Fukami, H. Satoh, E. Fujita, T. Maruyama, H. Fukuhara, M.
Kuramochi, S. Takamoto, T. Momoi, Y. Murakami, Identification of the
Tslc1 gene, a mouse orthologue of the human tumor suppressor TSLC1
gene, Gene 295 (2002) 7–12.
[11] S. Kakunaga, W. Ikeda, S. Itoh, M. Deguchi-Tawarada, T. Ohtsuka, A.
Mizoguchi, Y. Takai, Nectin-like molecule-1/TSLL1/SynCAM3: a neural
tissue-specific immunoglobulin-like cell –cell adhesion molecule localiz-
ing at non-junctional contact sites of presynaptic nerve terminals, axons
and glia cell processes, J. Cell Sci. 118 (2005) 1267–1277.
[12] Y. Takai, H. Nakanishi, Nectin and afadin: novel organizers of
intercellular junctions, J. Cell Sci. 116 (2003) 17–27.
[13] K. Irie, K. Shimizu, T. Sakisaka, W. Ikeda, Y. Takai, Roles and modes of
action of nectins in cell –cell adhesion, Semin. Cell Dev. Biol. 15 (2004)
643–656.
[14] T. Shingai, W. Ikeda, S. Kakunaga, K. Morimoto, K. Takekuni, S. Itoh,
K. Satoh, M. Takeuchi, T. Imai, M. Monden, Y. Takai, Implications of
nectin-like molecule-2/IGSF4/RA175/SgIGSF/TSLC1/SynCAM1 in
cell –cell adhesion and transmembrane protein localization in epithelial
cells, J. Biol. Chem. 278 (2003) 35421–35427.
[15] W. Ikeda, S. Kakunaga, S. Itoh, T. Shingai, K. Takekuni, K. Satoh, Y.
Inoue, A. Hamaguchi, K. Morimoto, M. Takeuchi, T. Imai, Y. Takai,
Tage4/nectin-like molecule-5 heterophilically trans-interacts with cell
adhesion molecule nectin-3 and enhances cell migration, J. Biol. Chem.
278 (2003) 28167–28172.
[16] P. Bork, L. Holm, C. Sander, The immunoglobulin fold: structural
classification, sequence patterns and common core, J. Mol. Biol. 242
(1994) 309–320.
[17] Y. Harpaz, C. Chothia, Many of the immunoglobulin superfamily domains
in cell adhesion molecules and surface receptors belong to a new structural
set which is close to that containing variable domains, J. Mol. Biol. 238
(1994) 528–539.
[18] D.M. Halaby, A. Poupon, J.P. Mornon, The immunoglobulin fold family:
sequence analysis and 3D structure comparisons, Protein Eng. 12 (1999)
563–571.
[19] D.K. Smith, H. Xue, Sequence profiles of immunoglobulin and
immunoglobulin-like domains, J. Mol. Biol. 274 (1997) 530–545.
[20] K.B. Hoover, P.J. Bryant, The genetics of the protein 4.1 family:
organizers of the membrane and cytoskeleton, Curr. Opin. Cell Biol. 12
(2000) 229–234.
[21] S.M. Marfatia, R.A. Leu, D. Branton, A.H. Chishti, Identification of the
protein 4.1 binding interface on glycophorin C and p55, a homologue of the
Drosophila discs-large tumor suppressor protein, J. Biol. Chem. 270 (1995)
715–719.
[22] N.J. Hemming, D.J. Anstee, M.A. Staricoff, M.J. Tanner, N. Mohandas,
Identification of the membrane attachment sites for protein 4.1 in the
human erythrocyte, J. Biol. Chem. 270 (1995) 5360–5366.
[23] R.F. Workman, P.S. Low, Biochemical analysis of potential sites forprotein 4.1-mediated anchoring of the spectrin–actin skeleton to the
erythrocyte membrane, J. Biol. Chem. 273 (1998) 6171–6176.
[24] T. Biederer, T.C. Su¨dhof, CASK and protein 4.1 support F-actin
nucleation on neurexins, J. Biol. Chem. 276 (2001) 47869–47876.
[25] Z. Songyang, A.S. Fanning, C. Fu, J. Xu, S.M. Marfatia, A.H. Chishti, A.
Crompton, A.C. Chan, J.M. Anderson, L.C. Cantley, Recognition of
unique carboxyl-terminal motifs by distinct PDZ domains, Science 275
(1997) 73–77.
[26] A.Y. Hung, M. Sheng, PDZ domains: structural modules for protein
complex assembly, J. Biol. Chem. 277 (2002) 5699–5702.
[27] H. Hutter, B.E. Vogel, J.D. Plenefisch, C.R. Norris, R.B. Proenca, J.
Spieth, C.B. Guo, S. Mastwal, X.P. Zhu, J. Scheel, E.M. Hedgecock,
Conservation and novelty in the evolution of cell adhesion and
extracellular matrix genes, Science 287 (2000) 989–994.
[28] O. Aurelio, D.H. Hall, O. Hobert, Immunoglobulin-domain proteins
required for maintenance of ventral nerve cord organization, Science 295
(2002) 686–690.
[29] R.O. Hynes, Q. Zhao, The evolution of cell adhesion, J. Cell Biol. 150
(2000) F89–F95.
[30] C. Vogel, S.A. Teichmann, C. Chothia, The immunoglobulin superfamily
in Drosophila melanogaster and Caenorhabditis elegans and the evolution
of complexity, Development 130 (2003) 6317–6328.
[31] G. Rougon, O. Hobert, New insights into the diversity and function of
neuronal immunoglobulin superfamily molecules, Annu. Rev. Neurosci.
26 (2003) 207–238.
[32] M. Masuda, M. Yageta, H. Fukuhara, M. Kuramochi, T. Maruyama, A.
Nomoto, Y. Murakami, The tumor suppressor protein TSLC1 is involved
in cell –cell adhesion, J. Biol. Chem. 277 (2002) 31014–31019.
[33] I.B. Wilson, Y. Gavel, G. von Heijne, Amino acid distributions around
O-linked glycosylation sites, Biochem. J. 275 (1991) 529–534.
[34] Y. Koma, A. Ito, T. Wakayama, K. Watabe, M. Okada, N. Tsubota, S.
Iseki, Y. Kitamura, Cloning of a soluble isoform of the SgIGSF adhesion
molecule that binds the extracellular domain of the membrane-bound
isoform, Oncogene 23 (2004) 5687–5692.
[35] B. Hassel, F.G. Rathjen, H. Volkmer, Organization of the neurofascin gene
and analysis of developmentally regulated alternative splicing, J. Biol.
Chem. 272 (1997) 28742–28749.
[36] H. Tachikui, N. Kurosawa, K. Kadomatsu, T. Muramatsu, Genomic
organization and promoter activity of embigin, a member of the
immunoglobulin superfamily, Gene 240 (1999) 325–332.
[37] A.F. Pimenta, P. Levitt, Characterization of the genomic structure of the
mouse limbic system-associated membrane protein (Lsamp) gene, Geno-
mics 83 (2004) 790–801.
[38] C.N. Tennyson, H.J. Klamut, R.G. Worton, The human dystrophin gene
requires 16 hours to be transcribed and is cotranscriptionally spliced, Nat.
Genet. 9 (1995) 184–190.
[39] E. Birney, M. Clamp, R. Durbin, GeneWise and genomewise, Genome
Res. 14 (2004) 988–995.
[40] C. Notredame, D.G. Higgins, J. Heringa, T-Coffee: a novel method for
fast and accurate multiple sequence alignment, J. Mol. Biol. 302 (2000)
205–217.
[41] J. Felsenstein, PHYLIP—Phylogeny inference package, Cladistics 5
(1989) 164–166.
[42] E.L. Sonnhammer, G. von Heijne, A. Krogh, A hidden Markov model for
predicting transmembrane helices in protein sequences, Proc. Int. Conf.
Intell. Syst. Mol. Biol. 6 (1998) 175–182.
[43] K. Nakai, P. Horton, PSORT: a program for detecting sorting signals in
proteins and predicting their subcellular localization, Trends Biochem.
Sci. 24 (1999) 34–35.
[44] K. Julenius, A. Molgaard, R. Gupta, S. Brunak, Prediction, conservation
analysis, and structural characterization of mammalian mucin-type O-
glycosylation sites, Glycobiology 15 (2005) 153–164.
[45] T. Fukami, H. Satoh, Y.N. Williams, M. Masuda, H. Fukuhara, T.
Maruyama, M. Yageta, M. Kuramochi, S. Takamoto, Y. Murakami,
Isolation of the mouse Tsll1 and Tsll2 genes, orthologues of the human
TSLC1-like genes 1 and 2 (TSLL1 and TSLL2), Gene 323 (2003) 11–18.
